Investors



EXCHANGE: NASDAQ
Change
Change (%)
Volume
Data as of
Minimum 15 minute delay
Refresh quote

LEARN MORE

Recent Press Releases

  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo” or the “Company”) (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the appointment of Christopher J. Gostout, MD, as its Chief Medical Officer. Dr. Gostout brings with him more than 30 years of experience in gastroenterology and hepatology with the Mayo Clinic in Rochester, Minnesota, and is a recognized key opinion leader onmore...
  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it has completed its merger transaction with Lpath, Inc. (“Lpath”, Nasdaq: LPTN). With the completion of the merger today, Lpath was renamed Apollo Endosurgery, Inc. and will begin trading on the NASDAQ Global Market under the symbol ‘APEN’ on December 30, 2016. Following themore...
Business Wire InvestorHQ℠